NCT03868124CompletedPhase 3
Clinical Study Comparing Two Models of a Travoprost Intraocular Implant
Prospective, Randomized Phase III Study Comparing Two Models of a Travoprost Intraocular Implant to Timolol Maleate Ophthalmic Solution, 0.5%
Source: ClinicalTrials.gov · Last updated 29 Nov 2024
Brief summary (registry, in English)
Phase III study to compare the safety and efficacy of intraocular implants containing Travoprost at two different elution rates versus Timolol Maleate Ophthalmic Solution, 0.5% (Timolol) in reducing elevated intraocular pressure in subjects with open angle glaucoma (OAG) or ocular hypertension (OHT)
- Status (registry)
- Completed
- Phase (registry)
- Phase 3
- Study type
- Interventional
- Enrollment
- 560 (actual)
- First submitted
- 6 Mar 2019
- Start date
- 17 Sept 2018
- Primary completion date
- 10 Jun 2022
- Lead sponsor
- Glaukos Corporation
- Diseases
- Glaucoma, High blood pressure
- NCT number
- NCT03868124
What you commit to
- Study type: Interventional · Phase 3
- Participants enrolled: 560
- From 17 Sept 2018 to the primary completion date, 10 Jun 2022
- 1 site in 1 country
- Visits and tests: ask the trial team, the registry does not list them
Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.
Who cannot take part
Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.
Other illness
- Retinal disorders not associated with glaucoma
Other
- Active corneal inflammation or edema
Who the study is looking for
- Diagnosed with open-angle glaucoma or ocular hypertension
- C/D ratio ≤ 0.8
- Zero to two preoperative ocular hypotensive medications
Age in the registry: 18 years to - · Sex: All · Does not accept healthy volunteers
Sites (1)
Sites in registry order. Pick your city on the disease page to sort them by distance.
| Site | City | Country | Site status |
|---|---|---|---|
| Center for Sight Coordinator of this site? Confirm its status | Las Vegas | United States | Unknown status |
This page is information, not medical advice. Discuss any trial with your doctor.